Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study

Keyphrases

• Estrogen 100%
• Cerebral Blood Flow 100%
• Cognitive Screening 50%
• Hamilton Depression Rating Scale (HAM-D) 50%
• Hamilton Anxiety Rating Scale 50%
• Premarin 50%
• BEHAVE-AD 50%
• Clinical Dementia Rating 50%
• Estrogen Therapy 50%
• Adverse Effects 25%
• Cognitive Performance 25%
• Amines 25%
• Single-photon Emission Computed Tomography (SPECT) 25%
• Oxime 25%
• Alzheimer's Disease 25%
• Primary Outcome Measure 25%
• Placebo-controlled 25%
• Cerebral Perfusion 25%
• Dementia Severity 25%
• Technetium-99m 25%
• Randomized Double-blind 25%
• Interview-based 25%
• AD Treatment 25%
• Behavioral Pathology 25%
• Meaningful Difference 25%
• Conjugated Estrogens 25%
• Clinician Interviews 25%
• Therapeutic Effectiveness 25%

Neuroscience

• Cognitive Function 100%
• Hamilton Rating Scale for Depression 100%
• Clinical Dementia Rating 100%
• Premarin 100%
• Behavior (Neuroscience) 50%
• Adverse Effect 50%
• Alzheimer's Disease 50%
• Single-Photon Emission Computed Tomography 50%
• Placebo 50%
• Technetium-99m 50%
• Oxime 50%

Psychology

• Mood 100%
• Rating Scale 100%
• Cerebral Blood Flow 100%
• Cognitive Function 50%
• Screening Instrument 50%
• Cognitive Performance 25%
• Alzheimer's Disease 25%